Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 7:58 pm Purchase | 2025-08-18 | 13G | Celldex Therapeutics, Inc. CLDX | Bellevue Group AG | 3,617,669 5.400% | 3,617,669 (New Position) | Filing History |
| 2025-11-14 5:08 pm Sale | 2025-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Commodore Capital LP | 3,028,335 4.600% | -321,665 (-9.60%) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | T. Rowe Price Associates, Inc. | 2,382,701 3.600% | -1,174,435 (-33.02%) | Filing History |
| 2025-11-07 08:18 am Purchase | 2025-10-31 | 13G | Celldex Therapeutics, Inc. CLDX | Wellington Management Group LLP | 7,394,746 11.100% | 2,162,420 (+41.33%) | Filing History |
| 2025-08-14 2:59 pm Sale | 2025-06-30 | 13G | Celldex Therapeutics, Inc. CLDX | Eventide Asset Management, LLC | 1,356,186 2.000% | -1,975,819 (-59.30%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Celldex Therapeutics, Inc. CLDX | Wellington Management Group LLP | 5,232,326 7.900% | -3,121,825 (-37.37%) | Filing History |
| 2025-07-10 4:10 pm Purchase | 2025-07-02 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 4,464,400 6.700% | 2,780,368 (+165.10%) | Filing History |
| 2025-05-15 11:48 am Purchase | 2025-03-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 6,500,000 9.790% | 1,435,793 (+28.35%) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Celldex Therapeutics, Inc. CLDX | Wellington Management Group LLP | 8,354,151 12.600% | -889,448 (-9.62%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Celldex Therapeutics, Inc. CLDX | BlackRock Inc. BLK | 4,819,293 7.300% | -661,377 (-12.07%) | Filing History |
| 2025-04-10 4:05 pm Purchase | 2025-04-03 | 13G | Celldex Therapeutics, Inc. CLDX | Commodore Capital LP | 3,350,000 5.000% | 3,350,000 (New Position) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Kynam Capital Management, LP | 5,064,207 7.630% | 2,058,303 (+68.48%) | Filing History |
| 2025-02-14 09:44 am Purchase | 2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | T. Rowe Price Associates, Inc. | 3,557,136 5.400% | 3,557,136 (New Position) | Filing History |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | FMR LLC | 4,857,668 7.300% | -1,166,748 (-19.37%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | BlackRock Inc. BLK | 5,480,670 8.300% | 1,804,978 (+49.11%) | Filing History |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 1,684,032 2.500% | -1,072,090 (-38.90%) | Filing History |
| 2024-11-14 12:18 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Eventide Asset Management, LLC | 3,332,005 5.030% | -298,008 (-8.21%) | Filing History |
| 2024-11-14 06:12 am Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | RTW Investments, LP | 0 0.000% | -3,463,201 (Position Closed) | Filing History |
| 2024-11-13 6:00 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Polar Capital Holdings Plc | 2,711,163 4.090% | -424,708 (-13.54%) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Celldex Therapeutics, Inc. CLDX | FMR LLC | 6,024,416 9.088% | -1,025,993 (-14.55%) | Filing History |